Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium bromide inhalation for cough after bronchoscopy in children
IRCT20211028052894N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ipratropium bromide in cough (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Number of cough episodes, Severity of cough and 5 more. Started Feb 2022; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20211028052894N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211028052894N1.